Liver Cancer Survivor: Dr. Andrew Tay
Patient Story
•
2020-08-31
To date I have done three rounds of ACTMonitor profiling to monitor the mutations of my liver tumor semi-annually.
“I highly recommend that cancer patients undergo genomic profiling – the new technology that is helpful to oncologists on the lookout for possible cancer recurrence. This technology can also assist the doctors in treatment selection so that the disease can be managed according to specific needs of the patient. Genomic profiling does provide an opportunity to extend the lives of cancer patients.“